
Release date: 2026-01-05 14:22:22 Article From: Lucius Laos Recommended: 30
It is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 19 deletion
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagolix sodium (trade name···【more】
Recommended:[list:visits]2026-06-07
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strictly contraindicated i···【more】
Recommended:[list:visits]2026-03-07
With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern f···【more】
Recommended:[list:visits]2026-02-07
The pharmaceutical industry in Laos started late and is limited in scale, with domestic drug supply ···【more】
Recommended:[list:visits]2026-01-07
Lucius Pharmaceuticals (Lao) Co., Ltd is a Lao pharmaceutical company established in 2020, headquart···【more】
Recommended:[list:visits]2026-30-06
The Lao generic pharmaceutical industry has developed rapidly in recent years, attracting increasing···【more】
Recommended:[list:visits]2026-29-06

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643